H

Hana Pharm Co Ltd
KRX:293480

Watchlist Manager
Hana Pharm Co Ltd
KRX:293480
Watchlist
Price: 11 220 KRW -0.44% Market Closed
Market Cap: 199.4B KRW

Intrinsic Value

The intrinsic value of one Hana Pharm Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 11 220 KRW, Hana Pharm Co Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Hana Pharm Co Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Hana Pharm Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Hana Pharm Co Ltd looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if Hana Pharm Co Ltd is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Hana Pharm Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Hana Pharm Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Hana Pharm Co Ltd.

Explain Valuation
Compare Hana Pharm Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Hana Pharm Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hana Pharm Co Ltd

Current Assets 106.3B
Cash & Short-Term Investments 2.3B
Receivables 43.3B
Other Current Assets 60.8B
Non-Current Assets 282B
Long-Term Investments 69.9B
PP&E 191.9B
Intangibles 16.5B
Other Non-Current Assets 3.6B
Current Liabilities 53.9B
Accounts Payable 7.2B
Accrued Liabilities 1.9B
Short-Term Debt 3B
Other Current Liabilities 41.7B
Non-Current Liabilities 24.3B
Long-Term Debt 8.7B
Other Non-Current Liabilities 15.6B
Efficiency

Free Cash Flow Analysis
Hana Pharm Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Hana Pharm Co Ltd

Revenue
230.1B KRW
Cost of Revenue
-88B KRW
Gross Profit
142.1B KRW
Operating Expenses
-117.6B KRW
Operating Income
24.5B KRW
Other Expenses
-4.6B KRW
Net Income
19.9B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Hana Pharm Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Sustainable 3Y Average Operating Margin
Healthy Operating Margin
hidden
Profitability
Score

Hana Pharm Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Hana Pharm Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Interest Coverage
Long-Term Solvency
Low D/E
High Altman Z-Score
hidden
Solvency
Score

Hana Pharm Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Hana Pharm Co Ltd

Wall Street analysts forecast Hana Pharm Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Hana Pharm Co Ltd is 16 320 KRW with a low forecast of 16 160 KRW and a high forecast of 16 800 KRW.

Lowest
Price Target
16 160 KRW
44% Upside
Average
Price Target
16 320 KRW
45% Upside
Highest
Price Target
16 800 KRW
50% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Hana Pharm Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Hana Pharm Co Ltd stock?

The intrinsic value of one Hana Pharm Co Ltd stock under the Base Case scenario is hidden KRW.

Is Hana Pharm Co Ltd stock undervalued or overvalued?

Compared to the current market price of 11 220 KRW, Hana Pharm Co Ltd is hidden .

Back to Top